Skip to main content

Presentations

2017

Kuwait workshop: Scheme best practices

Kuwait workshop: Total Quality Management – Microbiology Laboratories

SoGAT Trends in bacterial pathogen identification – molecular or not – that is the question

NIBSC workshop – Improving the Quality of Infectious Disease Diagnostics: The Role of EQA in Diagnostic Laboratories

Kuwait workshop: Good Laboratory Practice

2016

WHO IBVPD EQA

Rapid Diagnostics: Bacteriology & Mycology

NRL Hepatitis B serology scheme results

MICROBE What can we do for you?

Quality Assurance and Fungal Diagnostics

2015

Invasive Aspergillosis: EQA of Galactomannan as an Indicator of Disease

Antimicrobial Pipeline and Drug Development

Rapid Diagnostics to support Antimicrobial Stewardship

New for old: Selection, validation and verification under ISO 15189:2012

Species and agents supported (or not) by EUCAST breakpoints and methodology

Update on the UKNEQAS Interpretative Comments scheme in Microbiology

Faecal Transwab

Update on Virology, Molecular and Serology schemes

HIV1 RNA quantification

UKCMN UK NEQAS Benefits of an EQA Performance in the Last Decade

ECCMID CAESAR EQA results 2014

NCI Workshop – Impact of the introduction of the International Standards

LabQuality – Post analytical challenges in Microbiology

2014

Roche Diagnostics Molecular Days – An Overview of NEQAS functions

What is HTLV?

ECCMID CAESAR Results for AMR EQA 2013

Abbot Forum: Infeksjonsimmunologi – Update on UK NEQAS Serology schemes

2013

Update on Virology, Molecular and Serology schemes

How to be a good participant

UK NEQAS for Microbiology new website

General Bacteriology distribution report update

EQALM Finding the “Bugs” through EQA

Development of a UK NEQAS specimen for an EQA scheme for Pneumococcal Urinary Antigen Testing

2012

EUCAST Subcommitee for Detection of Resistance Mechanisms

EUCAST 2012 and on

Identifying the misidentification problems

Implementation of MALDI-TOF MS in a Routine Clinical Laboratory

2011

Introducing an Interpretating EQA scheme in Microbiology(Jane Stockley)

UK NEQAS for Microbiology Update on schemes and the future(Dr Vivienne James)

Badgers & Bovine TB(Dr Margaret Stoddart)

Gastroenteric viruses(Jim Gray)

Pathology A Vision for the Future(Dr Ian Barnes)

EUCAST in Europe(Gunnar Kahlmeter)

Anaerobic Microbiology and NEQAS(David Smith)

UKNEQAS A Critical Clinical Activity(David Bullock)

Feedback from the Antibiotic Assay Scheme(Andrew Lovering)

Joint Working Group EQA Performance Monitoring(Alec J Howat)

The under estimated burden of schistosomiasis and intestinal helminths(Alan Fenwick)

NEQAS Participant Feedback(Eric Martindale)

2009

UK NEQAS Microbiology(Erwin Brown)

Control of measles in England 1968-2009 and update on post-exposure prophylaxis(Mary Ramsay)

2008

UK Clinical Microbiology Network

A Consensus Method for Molecular Diagnostic Testing

Fungal Update – Antifungal Susceptibility Testing

External Quality Assessment in Mycology

Mycology Identification Scheme Dermatophyte Specimens

Molecular Identification of Fungi

2007

What’s in your Antimicrobial Assay Report?

Susceptibility testing methods in Europe: Does it make a difference?

Interventions to reduce inappropriate antibiotic prescribing in hospitals

Keeping score with NEQAS

Expert rules and their impact on interpretation